A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
University of Iowa
University of Iowa
Gilead Sciences
Eisai Inc.
Universitätsklinikum Hamburg-Eppendorf
PharmaEngine
UNC Lineberger Comprehensive Cancer Center
Oxford University Hospitals NHS Trust
Generic Devices Consulting, Inc.
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Tokyo University
Tokyo University
Sanofi